based on 27 analysts
33.33%
Buy
18.52%
Hold
48.15%
Sell
Based on 27 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹5512.44
Source: S&P Global Market Intelligence
Divis Laboratories Ltd price forecast by 27 analysts
Downside of
High
₹6983
Target
₹5512.44
Low
₹3590
Divis Laboratories Ltd target price ₹5512.44, a slight downside of -5.72% compared to current price of ₹5849.45. According to 27 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Divis Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2026:38.05%
Forecast
Actual
Including amortisation and stock based compensations
Divis Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2026:64.18%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.75 % |
3 Month Return | + 8.82 % |
1 Year Return | + 51.33 % |
Market Stats | |
Previous Close | ₹5,846.75 |
Open | ₹5,846.75 |
Volume | 4.64L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,55,212.84Cr |
P/E Ratio | 84.18 |
PEG Ratio | 4.43 |
Market Cap | ₹1,55,212.84 Cr |
P/B Ratio | 6.75 |
EPS | 60.38 |
Dividend Yield | 0.87 |
Sector | Pharmaceuticals |
ROE | 12.04 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
HOLD | ₹1,55,212.84 Cr | 44.67% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,16,318.47 Cr | 53.62% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
HOLD | ₹40,334.16 Cr | 3.52% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹29,198.95 Cr | -0.52% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
BUY | ₹1,18,884.82 Cr | 42.93% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Organisation | Divis Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Divis Laboratories Ltd
Citi Maintains Buy Rating Amid Growth Prospects - 10 Dec, 2024
Divis Laboratories Shares Decline Amid Legislative Uncertainty - 09 Dec, 2024
Divis Laboratories Shares Drop After Court Ruling - 06 Dec, 2024
Divis Labs Addresses Patent Ruling Concerns - 05 Dec, 2024
Divis Lab Reports Strong Q2 FY25 Financials - 03 Dec, 2024
Divis Laboratories Gains on Citi's Bullish Outlook - 29 Nov, 2024
Divis Laboratories Shares Show Modest Gains - 27 Nov, 2024
Divis Laboratories Shows Bullish Potential - 26 Nov, 2024
Divis Labs Shows Indecision Amid Price Increase - 25 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, DIVISLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
Revenue is up for the last 2 quarters, 2.19K Cr → 2.44K Cr (in ₹), with an average increase of 10.1% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 16.16% to 17.25% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 430.0 Cr → 510.0 Cr (in ₹), with an average increase of 15.7% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.3% return, outperforming this stock by 97.7%
Price Dip
In the last 1 month, DIVISLAB stock has moved down by -4.8%
Promoter Holding Down
Promoters have decreased holdings from 51.90% to 51.89% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 13.10% to 11.92% in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 10.18% to 9.80% in Sep 2024 quarter
News
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 51.89% | ||
Foreign Institutions | 17.25% | 6.77 | |
Mutual Funds | 11.92% | ||
Retail Investors | 9.8% | ||
Others | 9.14% | 5.47 |
Divis Laboratories Ltd in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (56.23x)
December 19, 2024
Today (84.18x)
December 19, 2024
Highest (90.48x)
December 4, 2024
Divis Laboratories Ltd’s net profit jumped 46.55% since last year same period to ₹510Cr in the Q2 2024-2025. On a quarterly growth basis, Divis Laboratories Ltd has generated 18.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Divis Laboratories Ltd has declared dividend of ₹30 - translating a dividend yield of 0.51%.
Read More about DividendsBearish
Neutral
Bullish
Divis Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Divis Laboratories Ltd (DIVISLAB) share price today is ₹5849.45
Divis Laboratories Ltd is listed on NSE
Divis Laboratories Ltd is listed on BSE
PE Ratio of Divis Laboratories Ltd is 84.18
PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share
Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 4.64L.
Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹155212.84Cr.
Divis Laboratories Ltd(DIVISLAB | Price |
---|---|
52 Week High | ₹6285.45 |
52 Week Low | ₹3350 |
Divis Laboratories Ltd(DIVISLAB) share price is ₹5849.45. It is down -6.94% from its 52 Week High price of ₹6285.45
Divis Laboratories Ltd(DIVISLAB) share price is ₹5849.45. It is up 74.61% from its 52 Week Low price of ₹3350
Divis Laboratories Ltd(DIVISLAB | Returns |
---|---|
1 Day Returns | 2.7% |
1 Month Returns | -4.75% |
3 Month Returns | 8.82% |
1 Year Returns | 51.33% |